Literature DB >> 7858854

Effects of cyclopiazonic acid on contractility and ecto-ATPase activity in guinea-pig urinary bladder and vas deferens.

A U Ziganshin1, C H Hoyle, L E Ziganshina, G Burnstock.   

Abstract

1. Cyclopiazonic acid (CPA), an inhibitor of sarcoplasmic ATPase, was tested on guinea-pig urinary bladder and vas deferens for its ability: (1) to modify contractile responses to electrical field stimulation (EFS), exogenous ATP, alpha,beta-methylene ATP (alpha,beta-MeATP), carbachol, noradrenaline (NA), histamine, and KCl; (2) to affect ecto-ATPase activity; (3) to modify the release of ATP evoked by EFS. 2. In the urinary bladder, CPA (10 microM) potentiated contractile responses to EFS, exogenous ATP (100 microM), alpha,beta-meATP (1 microM), carbachol (0.5 microM), histamine (30 microM) and KCl (30 mM). In the vas deferens, CPA (10 microM) potentiated responses to EFS, ATP, alpha,beta-meATP, NA (100 microM) and KCl. CPA at a concentration of 1 microM had no effect on ATP-induced relaxation of carbachol-precontracted guinea-pig taenia coli, and at a concentration of 10 microM it markedly increased spontaneous contractile activity of taenia. 3. Ecto-ATPase was estimated to have Vmax and Km values of 0.98 nmol Pi 30 min-1 mg-1 wet tissue and 881 microM ATP in the urinary bladder, and 0.75 nmol Pi 30 min-1 mg-1 wet tissue and 914 microM ATP in the vas deferens, respectively. CPA at a concentration of 10 microM significantly inhibited ecto-ATPase activity by 18% in the urinary bladder and by 24% in the vas deferens. 4. In the guinea-pig vas deferens, CPA significantly potentiated ATP release evoked by EFS from 2.2 +/- 0.8 (6) pmol ATP min-1 g-1 wet tissue to 35.2 +/- 4.8 (6) pmol ATP min-1 g-1 wet tissue (P < 0.01). 5. In conclusion, the potentiation of contractile responses of the guinea-pig urinary bladder and vas deferens by CPA has a non-specific character. CPA inhibited ecto-ATPase activity and increased ATP release, but these effects do not appear to contribute to the potentiation of Pu-purinoceptor-mediated responses since the contractile actions of all the agonists studied were potentiated to the same extent.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7858854      PMCID: PMC1510424          DOI: 10.1111/j.1476-5381.1994.tb17044.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  25 in total

1.  Mg2+-ATPase as a membrane ecto-enzyme of human granulocytes. Inhibitors, activators and response to phagocytosis.

Authors:  J E Smolen; G Weissmann
Journal:  Biochim Biophys Acta       Date:  1978-10-04

2.  The properties and extracellular location of 5'-nucleotidase of the rat fat-cell plasma membrane.

Authors:  A C Newby; J P Luzio; C N Hales
Journal:  Biochem J       Date:  1975-03       Impact factor: 3.857

3.  The structure-activity relationships of ectonucleotidases and of excitatory P2-purinoceptors: evidence that dephosphorylation of ATP analogues reduces pharmacological potency.

Authors:  L A Welford; N J Cusack; S M Hourani
Journal:  Eur J Pharmacol       Date:  1987-09-02       Impact factor: 4.432

4.  ATP analogues and the guinea-pig taenia coli: a comparison of the structure-activity relationships of ectonucleotidases with those of the P2-purinoceptor.

Authors:  L A Welford; N J Cusack; S M Hourani
Journal:  Eur J Pharmacol       Date:  1986-10-07       Impact factor: 4.432

5.  Drug-sensitive ecto-ATPase in human leukocytes.

Authors:  F Medzihradsky; E I Cullen; H L Lin; G G Bole
Journal:  Biochem Pharmacol       Date:  1980-09-01       Impact factor: 5.858

6.  Sympathetic nerve-mediated release of ATP from the guinea-pig vas deferens is unaffected by reserpine.

Authors:  K Kirkpatrick; G Burnstock
Journal:  Eur J Pharmacol       Date:  1987-06-19       Impact factor: 4.432

7.  The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladder.

Authors:  S M Hourani; J A Chown
Journal:  Gen Pharmacol       Date:  1989

8.  Actions of 4-aminopyridine on vascular smooth muscle tissues of the guinea-pig.

Authors:  Y Hara; K Kitamura; H Kuriyama
Journal:  Br J Pharmacol       Date:  1980-01       Impact factor: 8.739

9.  The potentiating effects of 4-aminopyridine on adrenergic transmission in the rabbit vas deferens.

Authors:  A Johns; D S Golko; P A Lauzon; D M Paton
Journal:  Eur J Pharmacol       Date:  1976-07       Impact factor: 4.432

10.  Relaxation of rat thoracic aorta induced by the Ca(2+)-ATPase inhibitor, cyclopiazonic acid, possibly through nitric oxide formation.

Authors:  H Moritoki; T Hisayama; S Takeuchi; W Kondoh; M Imagawa
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

View more
  9 in total

1.  β-Nicotinamide adenine dinucleotide acts at prejunctional adenosine A1 receptors to suppress inhibitory musculomotor neurotransmission in guinea pig colon and human jejunum.

Authors:  Guo-Du Wang; Xi-Yu Wang; Sumei Liu; Yun Xia; Fei Zou; Meihua Qu; Bradley J Needleman; Dean J Mikami; Jackie D Wood
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-03-26       Impact factor: 4.052

2.  Nerve-released acetylcholine contracts urinary bladder smooth muscle by inducing action potentials independently of IP3-mediated calcium release.

Authors:  Bernhard Nausch; Thomas J Heppner; Mark T Nelson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2010-06-23       Impact factor: 3.619

3.  EFFECT OF NEW PYRIDOXAL PHOSPHATE ARYLAZO DERIVATIVES ON THE ECTO-ATPase ACTIVITY IN GUINEA PIG TISSUES.

Authors:  A U Ziganshin; A P Zaitsev; I P Zaitseva; Yu Ch Kim; E Camaioni; G Burnstock; K A Jacobson
Journal:  Pharm Chem J       Date:  2000-05       Impact factor: 0.837

4.  N-linked oligosaccharides affect the enzymatic activity of CD39: diverse interactions between seven N-linked glycosylation sites.

Authors:  James J Wu; Lisa E Choi; Guido Guidotti
Journal:  Mol Biol Cell       Date:  2005-01-26       Impact factor: 4.138

5.  Functional consequences of inhibition of nucleotide breakdown in rat vas deferens: a study with Evans blue.

Authors:  R Bültmann; B Driessen; J Gonçalves; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

6.  High affinity P2x-purinoceptor binding sites for [35S]-adenosine 5'-O-[3-thiotriphosphate] in rat vas deferens membranes.

Authors:  A D Michel; P P Humphrey
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

7.  Nerve-evoked purinergic signalling suppresses action potentials, Ca2+ flashes and contractility evoked by muscarinic receptor activation in mouse urinary bladder smooth muscle.

Authors:  Thomas J Heppner; Matthias E Werner; Bernhard Nausch; Catherine Vial; Richard J Evans; Mark T Nelson
Journal:  J Physiol       Date:  2009-09-07       Impact factor: 5.182

Review 8.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

9.  Inhibitory action of PPADS on relaxant responses to adenine nucleotides or electrical field stimulation in guinea-pig taenia coli and rat duodenum.

Authors:  U Windscheif; O Pfaff; A U Ziganshin; C H Hoyle; H G Bäumert; E Mutschler; G Burnstock; G Lambrecht
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.